Skip to content

Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms

Emma I Kopra, Jason Ferris, Adam Winstock, Allan H. Young, James Rucker

Journal of Psychopharmacology April 7, 2022 DOI: 10.1177/02698811221084063 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Cross-sectional survey Peer reviewed
Sample size 9,233
Population Past year magic mushroom users who completed the 2017 Global Drug Survey
Duration 12-month prevalence
Topics Psilocybin
Keywords Adverse effect Magic telescope Medical emergency Anesthesia Pharmacology
Citations 65
Key findings Only 0.2% of past year magic mushroom users sought emergency medical treatment, and all but one recovered within 24 hours.

Abstract

Background: Psilocybin-containing mushrooms are used for recreational, spiritual, self-development and therapeutic purposes. However, physiologically relatively nontoxic, adverse reactions are occasionally reported.

Aims: This study investigated the 12-month prevalence and nature of magic mushroom-related adverse reactions resulting in emergency medical treatment seeking in a global sample of people reporting magic mushroom use.

Methods: We use data from the 2017 Global Drug Survey – a large anonymous online survey on patterns of drug use conducted between November 2016 and January 2017.

Results: Out of 9233 past year magic mushroom users, 19 (0.2%) reported having sought emergency medical treatment, with a per-event risk estimate of 0.06%. Young age was the only predictor associated with higher risk of emergency medical presentations. The most common symptoms were psychological, namely anxiety/panic and paranoia/suspiciousness. Poor ‘mindset’, poor ‘setting’ and mixing substances were most reported reasons for incidents. All but one respondent returned back to normality within 24 h.

Conclusions: The results confirm psilocybin mushrooms are a relatively safe drug, with serious incidents rare and short lasting. Providing harm-reduction information likely plays a key role in preventing adverse effects. More research is needed to examine the detailed circumstances and predictors of adverse reactions including rarer physiological reactions.

Comparable studies

Other cross-sectional and survey studies on psilocybin, most cited first.

Study Year Design Participants
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences Individuals who had consumed psilocybin mushrooms and experienced a psychologically... 2016 Cross-sectional survey n = 1,993
The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms Internet survey respondents reporting challenging experiences with psilocybin 2016 Questionnaire development and validation
Psychedelics and Mental Health: A Population Study Adult population in the United States 2013 Cross-sectional survey n = 130,152
Cessation and reduction in alcohol consumption and misuse after psychedelic use Individuals with prior alcohol use disorder who reported cessation or reduction in... 2019 Cross-sectional survey n = 343
Patterns of simultaneous polysubstance use in drug using university students Drug-using university students 2006 Cross-sectional survey n = 149

Citations in the library

Cited by 63

and 58 more in the library

Cites 42

and 37 more in the library

Explore topics